SAT110 Euglycemic Diabetes Ketoacidosis Associated With Sodium-glucose Cotransporter Inhibitors: A Case Series To Raise Awareness

Disclosure: D. Katwal: None. Y. Pokharel: None. M. Ghawji: None. Z. Liu: None. H.O. Steinberg: None. S. Dagogo-Jack: Consulting Fee; Self; AstraZeneca, Boehringer Ingelheim, Janssen Research & Development Company, Medtronic Diabetes, Merck & Co., Sanofi, Bayer, Inc. Research Investigator; Se...

Descripción completa

Detalles Bibliográficos
Autores principales: Katwal, Dilasha, Pokharel, Yasmina, Ghawji, Maher, Liu, Zhao, Steinberg, Helmut O, Dagogo-Jack, Samuel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Diabetes And Glucose Metabolism
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10553589/
http://dx.doi.org/10.1210/jendso/bvad114.975

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10553589/
http://dx.doi.org/10.1210/jendso/bvad114.975

Ejemplares similares